These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31202133)

  • 1. Glycosylation of viral surface proteins probed by mass spectrometry.
    Hargett AA; Renfrow MB
    Curr Opin Virol; 2019 Jun; 36():56-66. PubMed ID: 31202133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Spectrometry-Based Chemical and Enzymatic Methods for Global Analysis of Protein Glycosylation.
    Xiao H; Suttapitugsakul S; Sun F; Wu R
    Acc Chem Res; 2018 Aug; 51(8):1796-1806. PubMed ID: 30011186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific protein glycosylation analysis with glycan isomer differentiation.
    Hua S; Nwosu CC; Strum JS; Seipert RR; An HJ; Zivkovic AM; German JB; Lebrilla CB
    Anal Bioanal Chem; 2012 May; 403(5):1291-302. PubMed ID: 21647803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global and site-specific detection of human integrin alpha 5 beta 1 glycosylation using tandem mass spectrometry and the StrOligo algorithm.
    Ethier M; Krokhin O; Ens W; Standing KG; Wilkins JA; Perreault H
    Rapid Commun Mass Spectrom; 2005; 19(5):721-7. PubMed ID: 15702487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
    Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
    J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global aspects of viral glycosylation.
    Bagdonaite I; Wandall HH
    Glycobiology; 2018 Jul; 28(7):443-467. PubMed ID: 29579213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific glycosylation profile of influenza A (H1N1) hemagglutinin through tandem mass spectrometry.
    Cruz E; Cain J; Crossett B; Kayser V
    Hum Vaccin Immunother; 2018 Mar; 14(3):508-517. PubMed ID: 29048990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a Quantitative LC-MS Multiattribute Method for Monitoring Site-Specific Glycan Heterogeneity on a Monoclonal Antibody Containing Two N-Linked Glycosylation Sites.
    Wang T; Chu L; Li W; Lawson K; Apostol I; Eris T
    Anal Chem; 2017 Mar; 89(6):3562-3567. PubMed ID: 28199092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral glycoproteomes: technologies for characterization and outlook for vaccine design.
    Bagdonaite I; Vakhrushev SY; Joshi HJ; Wandall HH
    FEBS Lett; 2018 Dec; 592(23):3898-3920. PubMed ID: 29961944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining HIV-1 Envelope N-Glycan Microdomains through Site-Specific Heterogeneity Profiles.
    Hargett AA; Wei Q; Knoppova B; Hall S; Huang ZQ; Prakash A; Green TJ; Moldoveanu Z; Raska M; Novak J; Renfrow MB
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30305355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of glycosylation: structural determination of N- and O-linked glycans by mass spectrometry.
    Harvey DJ
    Expert Rev Proteomics; 2005 Jan; 2(1):87-101. PubMed ID: 15966855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reductive chemical release of N-glycans as 1-amino-alditols and subsequent 9-fluorenylmethyloxycarbonyl labeling for MS and LC/MS analysis.
    Wang C; Qiang S; Jin W; Song X; Zhang Y; Huang L; Wang Z
    J Proteomics; 2018 Sep; 187():47-58. PubMed ID: 29885470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the Epstein-Barr virus major envelope glycoprotein.
    Szakonyi G; Klein MG; Hannan JP; Young KA; Ma RZ; Asokan R; Holers VM; Chen XS
    Nat Struct Mol Biol; 2006 Nov; 13(11):996-1001. PubMed ID: 17072314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoding of O-Linked Glycosylation by Mass Spectrometry.
    Mulagapati S; Koppolu V; Raju TS
    Biochemistry; 2017 Mar; 56(9):1218-1226. PubMed ID: 28196325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific N-glycan characterization of human complement factor H.
    Fenaille F; Le Mignon M; Groseil C; Ramon C; Riandé S; Siret L; Bihoreau N
    Glycobiology; 2007 Sep; 17(9):932-44. PubMed ID: 17591618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-glycan profiles in H9N2 avian influenza viruses from chicken eggs and human embryonic lung fibroblast cells.
    Chen W; Zhong Y; Su R; Qi H; Deng W; Sun Y; Ma T; Wang X; Yu H; Wang X; Li Z
    J Virol Methods; 2017 Nov; 249():10-20. PubMed ID: 28797655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Method for Mapping Glycosylation Sites in Proteins.
    Han MS; Simpson JT
    J Biomol Tech; 2017 Dec; 28(4):142-149. PubMed ID: 29038641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Insight into Glyco-Microheterogeneity of Plasma von Willebrand Factor by Mass Spectrometry.
    Gashash EA; Aloor A; Li D; Zhu H; Xu XQ; Xiao C; Zhang J; Parameswaran A; Song J; Ma C; Xiao W; Wang PG
    J Proteome Res; 2017 Sep; 16(9):3348-3362. PubMed ID: 28696719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry in the characterization of human genetic N-glycosylation defects.
    Barone R; Sturiale L; Garozzo D
    Mass Spectrom Rev; 2009; 28(3):517-42. PubMed ID: 18844296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The analysis of alpha-1-antitrypsin glycosylation with direct LC-MS/MS.
    Yin H; An M; So PK; Wong MY; Lubman DM; Yao Z
    Electrophoresis; 2018 Sep; 39(18):2351-2361. PubMed ID: 29405331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.